• Journal of Nutrition and Health
• /
• 제10권1호
• /
• pp.18-21
• /
• 1977

Effects of alginate and tangle on the suppression of intestinal absorption of heavy metals were tested by albino rats. The absorption of cadmium was suppressed by adding 5% or 10% alginate to the diets contaminated with 5 ppm cadmium, but not by 1% a1ginate or 10% tangle (p<0.05).

• 한국식품과학회지
• /
• 제26권6호
• /
• pp.745-749
• /
• 1994

녹차음료가 음용수나 식품에 오염된 중금속의 장내흡수 및 체내 축적 억제와 같은 생리적 기능이 있는지를 조사하기 위해 동물실험을 실시하였다. 쥐에게 3주간 수질기준의 5,000배와 500배 수준으로 납과 카드뮴을 오염시킨 음료수를 부여했을 때 식이섭취량과 체중증가량은 카드뮴 고농도 부여군을 제외한 모든 군에서 중금속 투여로 인한 유의적 차이를 나타내지 않았다. 표적장기의 무게는 신장과 대퇴골에서 중금속 투여에 의한 유의적 차이를 나타냈으며 녹차 투여로 인한 장기무게에는 영향을 나타내지 않았다. 표적장기의 중금속 함량에 있어서는 녹차 음용에 의한 장기의 축적억제 효과를 나타냈는데 특히 대퇴골에서 납은 $25{\sim}45%$, 카드뮴은 고농도 투여군에서 42%의 뚜렷한 감소효과를 보였다. 대퇴골의 칼슘함량은 중금속 투여로 크게 낮아졌으나 녹차 투여 군에서는 그 함량이 증가하였으므로 녹차 투여로 중금속의 축적이 방해되어 칼슘흡수가 증가했음을 확인할수 있었다.

• Nutrition Research and Practice
• /
• 제4권6호
• /
• pp.462-469
• /
• 2010

Protamine has been widely used as a pharmaceutical product and natural food preservative. However, few studies have been conducted to assess the beneficial function of dietary protamine. This study examined the effects of dietary salmon protamine on serum and liver lipid levels and the expression levels of genes encoding proteins involved in lipid homeostasis in the liver of rats. Groups of male Wistar rats were fed AIN93G diet containing 2% or 5% protamine. After 4 weeks of feeding these diets, markedly decreased serum and liver cholesterol (CHOL) and triacylglycerol levels were noted. Increased activity of liver carnitine palmitoyltransferase-2 and acyl-CoA oxidase, which are key enzymes of fatty acid ${\beta}$-oxidation in the mitochondria and peroxisomes, was found in rats fed on protamine. Furthermore, rats fed protamine showed enhanced fecal excretion of CHOL and bile acid and increased liver mRNA expression levels of ATP-binding cassette (ABC) G5 and ABCG8, which form heterodimers and play a major role in the secretion of CHOL into bile. The decrease in triacylglycerol levels in protamine-fed rats was due to the enhancement of liver ${\beta}$-oxidation. Furthermore, rats fed protamine exhibited decreased CHOL levels through the suppression of CHOL and bile acid absorption and the enhancement of CHOL secretion into bile. These results suggest that dietary protamine has beneficial effects that may aid in the prevention of lifestyle-related diseases such as hyperlipidemia and atherosclerosis.

• Toxicological Research
• /
• 제20권2호
• /
• pp.143-151
• /
• 2004

This study was to investigate single and repeated-dose toxicities of CJ-11555, an anticirrhotic agent, in Sprague-Dawley (SO) rats. In single-dose oral toxicity study, the test article were administered once by gavage to males and females at dose levels of 0 and 2,000 mg/kg. No dead animals and abnormal necropsy findings were found in control and CJ-11555 treated group. Therefore, the approximate lethal dose of CJ-11555 was considered to be higher than 2,000 mg/kg in rats. In the 4-week repeated oral toxicity study, the test article was administered once daily by gavage to male and female rats at dose levels of 0, 10, 50 and 200 mg/kg/day for 4-weeks. In clinical signs, yellow-colored urine and yellow hair coat were observed in the 50 and 200 mg/kg male and female groups. In hematology, erythrocyte count and hemoglobin were significantly decreased in the 200mg/kg male and female groups. In serum biochemistry, total cholesterol was significantly increased and aspartate aminotransferase (AST) was significantly decreased in the 50 or 200 mg/kg male and female groups. In histopathological examinations, centrilobular hepatocellular hypertrophy in the liver, congestion and pigmentation in the spleen, hyaline droplets in the kidney were observed in the 50 and 200 mg/kg male and female groups. In toxicokinetic study, CJ-11555 was dose-dependent in systemic exposure and showed better absorption in female with minimum accumulation after multidosing. Based on these results, it was concluded that the 4-week repeated oral dose of CJ-11555 resulted in the suppression of AST activity and centrilobular hepatocellular hypertrophy in both sexes at a dose level of 50 or 200 mg/kg/day. The target organ was estimated to be liver, spleen and male's kidney. The no-observed-adverse-effect level (NOAEL) for CJ-11555 in rats following gavage for at least 4-week is 10 mg/kg/day.

• 고려인삼학회:학술대회논문집
• /
• 고려인삼학회 1993년도 학술대회지
• /
• pp.113-118
• /
• 1993

The lowering effect of cholesterol in Sprague Dawley rats was investigated with panaxydol which was purified from the petroleum ether soluble fraction(PESF) of Korean red ginseng. The level of total cholesterol(TC), Triglyceride(TG) and low density lipoprotein(LOL)-cholesterol in serum was reduced by $48\%,\;47\%\;and\;41\%,$ respectively while high density lipoprotein(HDL)-cholesterol was in creased up to $29\%$ as compared with their control values when the panaxydol(20 umoles. 5 mq/kq/day) was adminstered by intraperitoneal rout for 3 consecutive days along with a $1\%$ cholesterol diet. The hepatic ester cholesterol content which was increased in proportion to the cholesterol content of the diet in the control, clearly decreased with panaxydol administration to about $40\%$ regardless of the two diet cholesterol content. $1\%\;or\;2\%.$ A threshold of supression on the serum lipid levels in both administration routes was observed: the maximium suppression in i.p. and p.o. administration was observed to be at 5mq/kq b.w. and in the range of 50 - 100 mg/kg b.w., respectively. Panaxydol may reduce serum lipid and cholesterol levels by inhibiting cholesterol absorption and/or by modulating the cholesterol metabolism. at least in part.